Tacrolimus and Steroid

Accession number;06A1040539
Title;Tacrolimus and Steroid
Author; FURUE MASUTAKA (Kyushu Univ., JPN) NAKAHARA TAKESHI (Kyushu Univ., JPN) UCHI HIROSHI (Kyushu Univ., JPN) TAKEUCHI SATOSHI (Kyushu Univ., JPN)
Journal Title;Skin Research
Journal Code:Z0014C
ISSN:1347-1813
VOL.5;NO.Suppl.7;PAGE.47-51(2006)
Figure&Table&Reference;TBL.1, REF.22
Pub. Country;Japan
Language;Japanese
Abstract;Atopic dermatitis is a multifactorial and hereditary cutaneous allergic disease which requires various anti-symptomatic treatments. Therapeutic guidelines indicate standard treatments useful in daily dermatological clinics. The therapeutic mainstay is topical steroid and tacrolimus. Topical tacrolimus not only complement existing treatment options but also overcome some of the drawbacks of topical steroid therapy and fulfil the long-term needs of patients in preventing disease progression. In order to reduce the possible long-term adverse effects and increase the usefulness, it is important to monitor the clinical dose in daily clinics and to create a suitable combination therapy. (author abst.)